Dr Reddy’s Knocked Back On Rituximab In US

Biosimilar Rival To Rituxan Receives Complete Response Letter From FDA

 
• By David Wallace
  
Stop sign in front of US flag
Approval of Dr Reddy’s rituximab has been blocked in the US • Source: Shutterstock
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Biosimilars

More from Products